Add BrightSurf on Google Email

How two different types of immune cells help two billion people keep tuberculosis in check

Scientists discovered that B cells play a crucial role in controlling tuberculosis (TB) infections by directing helper T cells, known as T follicular helper (Tfh)-like cells, to granuloma tissue in the lungs where they can activate macrophages. This finding holds promise for developing better treatments and vaccines for TB.

SourceUniversity of Chicago·JournalNature Immunology·TypeExperimental study·DateApr 3, 2023

Cancer that spreads to the lung maneuvers to avoid being attacked by “killer” T cells

Cancer cells have been found to employ a strategy to evade the immune system's killer T cells by interacting with myeloid cells and suppressing type 1 interferon production. This natural pathway is crucial for recruiting killer T cells to combat cancer spread. Researchers hope to develop new therapeutic approaches, such as forcing tumo...

A readily available dietary supplement may reverse organ damage caused by HIV and antiretroviral therapy

A recent study found that the mitochondrial antioxidant MitoQ can reverse the detrimental effects of HIV and antiretroviral therapy on organs such as the brain, heart, and liver. The researchers used humanized mice infected with HIV and treated them with MitoQ for three months.

SourceUniversity of California - Los Angeles Health Sciences·JournalThe Journal of Infectious Diseases·TypeRandomized controlled/clinical trial·DateMar 24, 2023

Dual immunotherapy plus chemotherapy before surgery improves patient outcomes in operable lung cancer

A Phase II trial led by researchers from the University of Texas MD Anderson Cancer Center demonstrated that adding ipilimumab to a neoadjuvant combination of nivolumab plus platinum-based chemotherapy resulted in a major pathologic response in half of all treated patients with early-stage non-small cell lung cancer. The treatment also...

Fomepizole helps overcome antibiotic-resistant pneumonia in mice

Researchers found that fomepizole blocked energy production in bacteria and reduced bacterial burden in mice with pneumonia. The combination treatment prevented invasive disease development, suggesting a potential novel treatment for multidrug-resistant pneumococcal disease.

SourcePLOS·JournalPLOS Biology·TypeObservational study·DateMar 16, 2023

Researchers develop priorities for interventions to address health disparities in lung nodule management

Health disparities in lung nodule follow-up and treatment are a major concern, with Black and Latino patients at higher risk of delayed follow-up. Researchers have identified prioritized research questions to mitigate these disparities, focusing on patient-clinician communication and culturally trained multidisciplinary teams.

SourceBoston University School of Medicine·JournalAmerican Journal of Respiratory and Critical Care Medicine·TypeContent analysis·DateMar 15, 2023

Breakthrough drug combination remains safe and effective in patients with cystic fibrosis after four years

A multicenter study found that patients with cystic fibrosis can safely take a dual combination of CF modulator drugs for four years while maintaining previously achieved clinical improvement. This breakthrough therapy has improved the quality and length of patients' lives, with some even seeing a 15% increase in lung function.

SourceMedical University of South Carolina·JournalJournal of Cystic Fibrosis·TypeRandomized controlled/clinical trial·DateMar 15, 2023

Gene essential to making DNA appears to be a good target in minimizing pulmonary hypertension

Researchers discover that inhibiting a gene crucial for DNA production can significantly reduce destructive cell proliferation and disease progression in pulmonary hypertension. This finding presents a potential treatment target for the condition, which affects females aged 30-60 with limited treatment options.

SourceMedical College of Georgia at Augusta University·JournalEuropean Heart Journal·DateMar 14, 2023

CHEST releases clinical practice guideline on respiratory management of patients with neuromuscular weakness

The American College of Chest Physicians released a clinical practice guideline on respiratory management for patients with neuromuscular weakness, providing evidence-based recommendations for mouthpiece ventilation and airway clearance therapies. The guideline aims to improve care for this vulnerable population.

SourceAmerican College of Chest Physicians·Journalthe journal CHEST·DateMar 14, 2023

In search of inflammatory Achilles heel

Researchers at Kyoto University found that neutrophils instruct macrophages to form a bacteria-permissive microenvironment, which could have implications for cancer treatment. The study suggests that A9, an enzyme expressed in neutrophils, may play a key role in this process.

SourceKyoto University·JournaliScience·TypeExperimental study·DateMar 9, 2023

New stem cell model developed for research into a life-threatening malformation of the newborn lung

Researchers have created a new patient-specific cell model to investigate the cause of congenital diaphragmatic hernia and explore potential treatments. The study found that inflammation alters stem cells in affected lungs, but drug therapy can restore functionality.

SourceUniversität Leipzig·JournalAmerican Journal of Respiratory and Critical Care Medicine·TypeExperimental study·DateMar 9, 2023

Fungal spores hijack lung cells

Researchers have discovered that fungal spores can exploit the human protein p11 to hijack lung cells and prevent them from destroying the fungus. This finding offers a promising new target for treatment against Aspergillus fumigatus infections, which affect over 300,000 people worldwide each year.

High-dose anticoagulation can reduce intubations and improve survival for hospitalized COVID-19 patients

High-dose anticoagulation reduces intubations and deaths by 30% in hospitalized COVID-19 patients, especially those with ARDS. The study found a significant reduction in mortality and need for ICU care among patients treated with therapeutic anticoagulation.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateMar 6, 2023

Physical activity and tailored support fails to deliver lasting benefits for smokers not ready to quit

A recent study found that promoting physical activity and behavioral support can help smokers reduce their smoking in the short-term, but delivering lasting benefits is challenging. The research, which recruited over 900 smokers, discovered that engaging with motivational support had some initial benefits, but only a small percentage o...

SourceUniversity of Plymouth·JournalAddiction·TypeRandomized controlled/clinical trial·DateMar 5, 2023

Death rates from lung cancer will fall overall in the EU and UK in 2023, but rise among women in France, Italy and Spain

Lung cancer death rates are projected to decrease overall in the EU and UK in 2023, however, a concerning trend is observed among women in France, Italy, and Spain. Meanwhile, pancreatic cancer death rates are forecasted to rise among women due to continued smoking habits.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·TypeObservational study·DateMar 5, 2023

Importance of early-life factors identified in new lung health study

A comprehensive study has identified key early-life factors that negatively affect lung function in young adults. The research analyzed data from over 7,500 participants and found that factors such as mother's weight during pregnancy, birthweight, and body composition at primary school have a significant impact on lung health.

SourceUniversity of Essex·JournalEuropean Respiratory Journal·TypeObservational study·DateMar 2, 2023

Children’s lung capacity improved in cleaner air

A new study published in the European Respiratory Journal reports that children's lung capacity has improved in areas with decreased air pollution in Stockholm. The researchers found a 20% lower risk of significantly impaired lung function in participants living in areas with better air quality.

SourceKarolinska Institutet·JournalEuropean Respiratory Journal·TypeObservational study·DateFeb 23, 2023

Yeast used in production of cachaça can prevent asthma, study shows

A Brazilian study found that a strain of brewer's yeast can act as a preventive against asthma in male mice. Daily administration of the probiotic at a dose of 10 billion CFU/mL significantly reduced bronchial hypersensitivity and inflammation. However, airway and lung inflammation was not significantly reduced by lower doses.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalProbiotics and Antimicrobial Proteins·DateFeb 22, 2023

Tuberculosis patients see dramatic cut in treatment duration, treatment effectiveness remains

A groundbreaking study found that a new TB treatment strategy can shorten treatment duration while maintaining effectiveness. The TRUNCATE-TB trial showed that an initial 8-week treatment period followed by retreatment for those not cured was as effective as the standard 6-month treatment but halved the average total time on treatment.

SourceNational University of Singapore, Yong Loo Lin School of Medicine·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateFeb 20, 2023

Early-stage lung disease could be detected with advanced imaging tech

A new study reveals that phase-contrast X-ray imaging can visualize smallest airways and their obstructions, potentially detecting early-stage lung disease. This technique could provide better resolution and contrast than conventional radiography, enabling subtle pathological changes to be seen.

SourceKTH, Royal Institute of Technology·JournalProceedings of the National Academy of Sciences·TypeObservational study·DateFeb 15, 2023

Tobacco and e-cigs may put healthy young people at risk of severe COVID illness, new UCLA research suggests

New UCLA research finds that tobacco smoking and vaping can predispose healthy young people to increased inflammation and severe COVID-19. The study, published in Journal of Molecular Medicine, found higher levels of key proteins in plasma from smokers and vapers compared to non-smokers.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of Molecular Medicine·TypeExperimental study·DateFeb 9, 2023

Scientists discover receptor that blocks COVID-19 infection

Researchers identified a protein in lung cells that blocks SARS-CoV-2 infection and forms a natural protective barrier. The discovery opens up an entirely new area of immunology research around LRRC15 and offers promising prospects for developing new drugs to prevent viral infection or treat fibrosis in the lungs.

SourceUniversity of Sydney·JournalPLOS Biology·TypeExperimental study·DateFeb 9, 2023

Discovery of T-cells that protect against deadly pneumococcal disease

A study by University of Liverpool researchers reveals how a unique subset of lung T regulatory cells provide resistance to bacteraemic pneumonia. These cells, known as TNFR2 expressing Tregs, play a critical role in maintaining and controlling frontline host immune responses when pneumococci infect the lungs. The findings have signifi...

SourceUniversity of Liverpool·JournalCell Reports·TypeExperimental study·DateFeb 8, 2023

E-cigarettes potentially harmful: PET imaging shows greater lung inflammation in e-cigarette users than cigarette smokers

A new study published in The Journal of Nuclear Medicine found that e-cigarette users have greater lung inflammation than cigarette smokers and non-smokers. The study used PET imaging to compare lung inflammation between e-cigarette users and cigarette smokers, revealing a unique inflammatory response in the lungs.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJan 26, 2023

How do e-cigarettes affect the lungs?

A new study found that prolonged inhalation of e-cigarette aerosols by mice caused changes in pulmonary immune cell composition and altered gene and protein levels in the lungs. Even low exposure to JUUL aerosols had significant impacts on the animals' lung health.

SourceWiley·JournalThe FASEB Journal·DateJan 25, 2023

AI improves detail, estimate of urban air pollution

Researchers developed machine learning models to accurately calculate fine particulate matter in urban air pollution using AI and traffic data. The models provide a high-resolution estimation of city street pollution surface, enabling transportation and epidemiology studies to assess health impacts.

SourceCornell University·JournalTransportation Research Part D Transport and Environment·DateJan 13, 2023

How sex differences influence lung injury in mice

Researchers have discovered that more than 2,500 genes exhibit significant sex differences in expression in mouse alveolar type II cells, potentially explaining sex biases in lung diseases. These findings suggest that AT2 cells may play a crucial role in sex-biased differences in lung injury and repair.

SourceCell Press·JournalStem Cell Reports·TypeExperimental study·DateJan 12, 2023

UCalgary study offers new insight into deadly fungal invasion of the lungs

Researchers discovered that viral infections like SARS-CoV-2 and influenza destroy a natural immunity needed to resist fungal infections. This leads to impaired cooperation between white blood cells, allowing fungi to take root. The study reveals potential repurposing of current therapies to replace damaged antibodies.

SourceUniversity of Calgary·JournalScience Translational Medicine·TypeExperimental study·DateJan 12, 2023